Deep Track Capital, LP
Q4 2025 13F Holdings
- Locationgreenwich, CT
- Num holdings
55
- Value ($000)
$5,608,748
- Date Filed02/13/2026
- Form type13F-HR
- CIK0001856083
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
SPDR SERIES TRUST | STATE STREET SPD | 78464A870 | $1.22B | 22 % | 10,000,000 | put | |
IMMUNOVANT INC | COM | 45258J102 | $293.02M | 5 % | 11,526,971 | ||
GUARDANT HEALTH INC | COM | 40131M109 | $285.99M | 5 % | 2,800,000 | ||
STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | $285.97M | 5 % | 4,111,782 | ||
TARSUS PHARMACEUTICALS INC | COM | 87650L103 | $245.97M | 4 % | 3,004,034 | ||
DYNAVAX TECHNOLOGIES CORP | COM NEW | 268158201 | $241.87M | 4 % | 15,726,349 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | $212.03M | 4 % | 3,336,998 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | $210.04M | 4 % | 1,150,000 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | $194.68M | 4 % | 7,750,000 | ||
VAXCYTE INC | COM | 92243G108 | $184.56M | 3 % | 4,000,000 |
Rows Per Page
10
- 5
- 10
- 20
- 30
- 50
- 100